Tekla Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$9.41M Hold
2022
Q4
$8.8M Buy
2022
Q3
$6.1M Hold
2022
Q2
$6M Hold
2022
Q1
$6.38M Buy
2021
Q4
$6.61M Hold
2021
Q3
$5.16M Hold
2021
Q2
$3.11M Hold
2021
Q1
$5.32M Buy
2017
Q3
Sell
2017
Q2
$3.26M Hold
2017
Q1
$3.1M Hold
2016
Q4
$3.18M Sell
2016
Q3
$7.38M Hold
2016
Q2
$5.88M Hold
2016
Q1
$4.51M Hold
2015
Q4
$6.37M Buy